Quarterly report pursuant to Section 13 or 15(d)

Significant Accounting Policies (Tables)

v3.22.2.2
Significant Accounting Policies (Tables)
6 Months Ended
Jul. 31, 2022
Accounting Policies [Abstract]  
Summary of Cash, Cash Equivalents, and Restricted Cash

The following table provides a summary of (i) cash and cash equivalents and (ii) restricted cash in the condensed consolidated statements of cash flows as of the periods presented:

 

 

As of July 31,

 

 

 

2022

 

 

2021

 

 

 

(Amounts in thousands)

 

Cash and cash equivalents

 

$

14,336

 

 

$

18,933

 

Restricted cash

 

 

290

 

 

 

350

 

Total cash, cash equivalents and restricted cash

 

$

14,626

 

 

$

19,283

 

 

Restricted cash is included as a component of other assets in the condensed consolidated balance sheets.

 

 

 

As of January 31,

 

 

 

2022

 

 

2021

 

 

 

(Amounts in thousands)

 

Cash and cash equivalents

 

$

17,528

 

 

$

5,856

 

Restricted cash

 

 

328

 

 

 

228

 

Total cash, cash equivalents and restricted cash

 

$

17,856

 

 

$

6,084

 

Schedule of Anti-dilutive Securities Excluded from Computation of Net (Loss) Income Per Share

The number of common shares used in the computation of diluted net (loss) income per share for the periods presented does not include the effect of the following potentially outstanding common shares because the effect would have been antidilutive:

 

 

 

For the Three Months
Ended July 31,

 

 

For the Six Months
Ended July 31,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

 

 

(Amounts in thousands)

 

 

(Amounts in thousands)

 

Stock options

 

 

1,172

 

 

 

1,453

 

 

 

1,205

 

 

 

1,671

 

Restricted stock units

 

 

448

 

 

 

113

 

 

 

8

 

 

 

124

 

Deferred stock units

 

 

 

 

 

62

 

 

 

 

 

 

41

 

 

 

 

1,620

 

 

 

1,628

 

 

 

1,213

 

 

 

1,836

 

Schedule of Dilutive Securities Included from Computation of Net Income Per Share

The number of common shares used in the computation of diluted net income per share for the period presented includes the effect of the following potentially outstanding common shares:

 

 

 

For the Three Months Ended July 31, 2021

 

 

 

(Amounts in thousands)

 

Restricted stock units

 

 

159

 

Deferred stock units

 

 

79

 

 

 

 

238